Dr. Michael Xuan Le, MD

Dr. Le practices at WellSpan Ephrata Community Hospital in Ephrata, Pennsylvania, part of WellSpan Health.

Dr. Le's NPI, 1225490329, was assigned on March 28, 2016. Dr. Le holds Pennsylvania license MD467257.

Dr. Le's primary practice is WellSpan Ephrata Community Hospital, at 169 Martin Avenue, Ephrata, PA 17522 in Lancaster County. The practice phone is (717) 733-0311.

Dr. Le's primary practice is WellSpan Ephrata Community Hospital in Ephrata, Pennsylvania, part of WellSpan Health. The medical group on file is WellSpan Digestive Health. Dmand AI also links Dr. Le to 1 more group practice or clinic, 1 therapy and rehab clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Le practices, 3 sites in all. Vendor and product names are available with a free account.

Hospitalist is Dr. Le's primary specialty in the NPI Registry, under taxonomy code 208M00000X. Dr. Le is licensed in Pennsylvania.

CMS data shows 723 Medicare services from Dr. Le across 6 procedure codes in 2024, for 286 Medicare patients. Medicare paid $60,837 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 286 Medicare patients who saw Dr. Le in 2024. The largest group is 85 and over, with 94 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 16% are also on Medicaid. Their average risk score is 2.00, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Le's median patient age at 78, with 44% women.

In 2024, Dr. Le wrote 571 Medicare Part D claims for 235 patients. 88% of them were for generic drugs. CMS names the drug for 293 of them, across 15 drugs with 11 or more claims each, at $11,873 in total drug cost. In 2023, CMS named 348 claims across 17 drugs.

Dr. Le accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 6 papers to Dr. Le, published from 2013 to 2022. 2018 was the busiest year, with 2. The most frequent topics are B-Lymphocytes, Cytidine Deaminase and DNA Breaks, Double-Stranded. Dr. Le's most frequent co-authors are Amit Chopra, MD, Andrew J. Evans, MD and Girish S. Kulkarni, MD, PhD.

CMS Open Payments shows 1 general payment to Dr. Le from 1 drug or device company in 2022. Food and beverage make up the largest share, 100% of the total. Novartis Pharmaceuticals Corporation paid the most, $17.